Document is current
Any future updates will be listed below
-
Authors
Prisciandaro, J J
Tolliver, B K
Prescot, A P
Brenner, H M
Renshaw, P F
Brown, T R
Anton, R F
- License Information
-
More Information
Article History
Received: 24 March 2017
Revised: 9 May 2017
Accepted: 15 May 2017
First Online: 4 July 2017
Competing interests
: PFR consults for Kyowa Hallo and Tal Medical. RFA has been a consultant in the recent past for Lilly, Lundbeck, Novartis, Indivior and Alkermes, and on Advisory Boards for Alkermes, Indivior and Lundbeck. He has received grant funds from Lilly. He is a member of the Alcohol Clinical Trials Initiative (ACTIVE) sponsored by the American Society of Clinical. Psychopharmacology (ASCP) which has been supported in the last 3 years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer and XenoPort. The remaining authors declare no conflict of interest.
